Kactus Biosystems(Shanghai)Co., Ltd.
恺佧生物
Kactus Biosystems(Shanghai)Co., Ltd.
Biotech/Healthcare
Kaika Bio is a target-protein R&D platform focused on the immunotherapy and diagnostics markets. It has developed a proprietary platform for innovative functional recombinant proteins and antibodies, called Structure-Aided Design and Multiplex Screening (SAMS™).
Latest round: Series B (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-10-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.